FIELD: medicine.
SUBSTANCE: complex antigen of measles virus used as a component of immunoenzymometric test system for diagnostics of antibodies to measles virus was produced from culture liquid containing measles virus stain Leningrad 16 with titer no less than 105.0 50% tissue cytopathic dose/ml, Edmonston - no less than 106.0 50% tissue cytopathic dose/ml, NovO/96 no less than 108.0 50% tissue cytopathic dose/ml by inactivation of its infectious activity by detergent and separation of protein from cellular lysate by chromatographic purification in amount no less than 2 mcg/ml with the purity no less than 70%. Culture virus-containing liquid was processed using separate cultivation of measles virus stains Leningrad 16, Edmonston and NovO/96 on monolayer of Vero cells culture with subsequent mixing of culture virus containing liquid in proportion 1:1:1 v/v.
EFFECT: Usage of invention provides for increased sensitivity and specificity of a complex antigen possessing the property to detect antibodies in blood serum.
2 cl, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF MEASLES VIRUS NOVO/96 FOR PREPARING ANTIGEN AS COMPONENT OF TEST-SYSTEM AND IMMUNOENZYME TEST-SYSTEM FOR DIAGNOSIS OF ANTIBODIES RAISED TO MEASLES VIRUS | 2002 |
|
RU2230785C2 |
| DRAGOON STRAIN OF PAROTITIS VIRUS FOR OBTAINING ANTIGENE COMPONENT OF TEST SYSTEM, AND IMMUNOENZYME TEST SYSTEM FOR PAROTITIS VIRUS ANTIBODY DIAGNOSTICS | 2007 |
|
RU2348691C1 |
| STRAIN OF MEASLES VIRUS FOR PREPARING IMMUNOBIOLOGICAL PREPARATIONS | 1992 |
|
RU2035509C1 |
| HSOBIENS-WT/GIN/2015/KALIDIE-KINDIA-1022 STRAIN OF EBOLA ZAIRE TO OBTAIN ANTIGEN USED AS COMPONENT OF IMMUNOENZYMOMETRIC TEST SYSTEM FOR DETECTION OF G AND M ANTIBODIES TO VIRUS OF EBOLA | 2016 |
|
RU2631937C1 |
| STRAIN OF HCOV-19/RUSSIA/OMSK-202118-1707/2020 OF SARS-COV-2 CORONAVIRUS, IMMUNOSORBENT CONTAINING PURIFIED WHOLE VIRION ANTIGEN OBTAINED ON BASIS OF SPECIFIED STRAIN AND ISA TEST SYSTEM FOR DETECTING ANTIBODIES OF CLASSES M, G AND A TO SARS CORONAVIRUS-COV-2 USING SPECIFIED IMMUNOSORBENT | 2021 |
|
RU2752862C1 |
| METHOD OF MEASLES VIRUS CULTIVATION | 1994 |
|
RU2053297C1 |
| MANUFACTURE METHOD OF BLOOD SERUM STANDARD POSITIVE PANEL FOR QUALITY CONTROL OF IMMUNOENZYMOMETRIC TEST SYSTEMS DESIGNED FOR DETECTION OF VIRUS-SPECIFIC ANTIBODIES TO VIRAL RESPIRATORY INFECTIONS IN BIOLOGICAL LIQUIDS OF BOVINE ANIMALS | 2008 |
|
RU2392331C2 |
| METHOD OF PREPARING LIVE MEASLES VACCINE FOR ORAL USING AND METHOD OF IMMUNIZATION AGAINST MEASLES | 1997 |
|
RU2133625C1 |
| VIRUS STRAIN FOR PRODUCING VACCINE DRUGS AGAINST HEMORRHAGIC FEVER WITH RENAL SYNDROME (OPTIONS) | 2018 |
|
RU2683508C1 |
| IMMUNOASSAY SYSTEM FOR DETERMINING CLASS A (IgA) ANTIBODIES AGAINST POLIOVIRUS IN HUMAN SALIVA FOR ASSESSING LEVEL OF MUCOSAL IMMUNITY TO THIS VIRUS | 2024 |
|
RU2829655C1 |
